OneMedNet financials
$6.33+873.85%
Close Sep 28, 2026 · split-adjustedToday's change is unusually large and no split is on record yet; it may reflect an unadjusted corporate action.
Revenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $292.0K | $96.0K | $891.0K | $177.0K | $155.0K | $137.0K | $26.0K | $142.0K | $227.0K | $248.0K | $340.0K |
| Gross profit | -$565.0K | -$380.0K | $165.0K | -$222.0K | -$241.0K | -$224.0K | -$26.0K | -$84.0K | -$102.0K | -$69.0K | $2.0K |
| Gross margin | −193.5% | −395.8% | 18.5% | −125.4% | −155.5% | −163.5% | −100.0% | −59.2% | −44.9% | −27.8% | 0.6% |
| Operating income | -$2.3M | -$2.6M | -$3.1M | -$2.2M | -$2.1M | -$2.2M | -$2.7M | -$2.3M | -$2.5M | -$2.1M | -$1.9M |
| Net income | -$2.2M | -$2.5M | -$3.1M | -$741.0K | $3.0M | -$1.9M | -$2.4M | -$2.1M | -$3.6M | -$2.1M | -$2.5M |
| Net margin | −743.8% | −2555.2% | −352.4% | −418.6% | 1923.9% | −1388.3% | −9126.9% | −1449.3% | −1581.1% | −850.4% | −734.1% |
| Diluted EPS | $-0.04 | $-0.04 | $-0.06 | $-0.01 | $0.07 | $-0.06 | $-0.07 | $-0.07 | $-0.14 | $-0.08 | $-0.15 |
| EBITDA | -$2.3M | -$2.5M | -$3.1M | -$2.2M | -$2.0M | -$2.2M | -$2.7M | -$2.3M | -$2.4M | -$2.1M | -$1.9M |
| Operating cash flow | -$1.9M | -$1.5M | -$1.7M | -$1.6M | -$2.2M | -$1.9M | -$2.0M | -$1.9M | -$1.5M | -$1.5M | -$1.7M |
| Free cash flow | -$1.9M | -$1.5M | -$1.7M | -$1.6M | -$2.2M | -$1.9M | -$2.0M | -$1.9M | -$1.5M | -$1.6M | -$1.7M |
| Diluted shares | 58.0M | 55.3M | 53.1M | 52.6M | 38.4M | 34.1M | 32.9M | 29.3M | 25.2M | 24.9M | 16.7M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $358.0K | $233.0K | $585.0K | $149.0K | $122.0K | $144.0K |
| Short-term investments | $0.00 | $66.0K | $506.0K | $600.0K | $0.00 | $793.0K |
| Total debt | $701.0K | $837.0K | $974.0K | $388.0K | $400.0K | $7.5M |
| Total assets | $1.4M | $1.5M | $2.2M | $1.5M | $2.3M | $1.7M |
| Total liabilities | $4.9M | $5.6M | $5.1M | $5.4M | $6.2M | $18.3M |
| Shareholders' equity | -$3.5M | -$4.1M | -$3.0M | -$3.9M | -$3.8M | -$16.6M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology